Please assess the completion status of the following clinical trial:

Trial Title: Caffeine for Apnea of Prematurity (CAP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* birthweight 500 to 1250 grams~* postnatal age day 1 to day 10~* infant considered a candidate for methylxanthine therapy by clinical staff~Exclusion Criteria:~* dysmorphic features or congenital malformations that adversely affect life expectancy or neurodevelopment~* unlikely to comply with long-term follow-up~* prior treatment with a methylxanthine

- Gender: ALL
- Minimum Age: None
- Maximum Age: 10 Days
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).